Kalaris Therapeutics Inc (KLRS) Financials

$2.50

$0.06 (-2.34%)
Last update: 01:00 PM EST
Day's range
$2.5
Day's range
$2.68
$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20MEarning20222022202320234%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

KLRS Income statement / Annual

Last year (2023), Kalaris Therapeutics Inc's total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Kalaris Therapeutics Inc's net income was -$14.70 M. See Kalaris Therapeutics Inc,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022
Period Ended 12/31/2023 12/31/2022
Operating Revenue $0.00 $0.00
Cost of Revenue $0.00 $0.00
Gross Profit $0.00 $0.00
Gross Profit Ratio 0 0
Research and Development Expenses $11.71 M $11.76 M
General & Administrative Expenses $1.76 M $2.24 M
Selling & Marketing Expenses $0.00 $0.00
Selling, General & Administrative Expenses $1.76 M $2.24 M
Other Expenses $0.00 $0.00
Operating Expenses $13.46 M $14.01 M
Cost And Expenses $13.46 M $14.01 M
Interest Income $0.00 $0.00
Interest Expense $687.00 K $235.00 K
Depreciation & Amortization $0.00 $0.00
EBITDA -$14.01 M -$15.25 M
EBITDA Ratio 0 0
Operating Income Ratio 0 0
Total Other Income/Expenses Net -$1.24 M -$1.48 M
Income Before Tax -$14.70 M -$15.49 M
Income Before Tax Ratio 0 0
Income Tax Expense $0.00 $0.00
Net Income -$14.70 M -$15.49 M
Net Income Ratio 0 0
EPS 0 0
EPS Diluted 0 0
Weighted Average Shares Out $0.00 $0.00
Weighted Average Shares Out Diluted $0.00 $0.00
Link